Pay in 4 interest-free payments of $6.82 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
A realistic UK approval window is late 2027 to mid 2028, with NHS availability through NICE technology appraisal arriving in 2029 at the earliest
The most clinically advanced approach is that taken by DIOSynVax (Digitally Immune Optimised Synthetic Vaccines), who have partnered with PharmaJet for a first-in-human needle-free intradermal vaccine pEVAC-PS encoding their synthetic antigen T2_17 based on coronavirus RBD sequences (Table 3) [152]
You should not submit a Yellow Card report for events occurring within a clinical trial unless specifically instructed to do so by the study team
Orders ship from Ontario, Canada
However, these factors are secondary to temperature
I always teach my students that in pharmacology, its about your judgement around whether something is benefiting the patient or not, says Ouanounou
